Generium
generium.ru
Actively hiring
Manufacturing
Pharmaceuticals
Biotechnology
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
Overview
«ГЕНЕРИУМ» — российский лидер в области биотехнологических разработок и производства Разрабатываем лекарственные препараты для лечения тяжелых наследственных заболеваний от молекулы до промышленного выпуска. Контроль качества на каждом этапе, соответствие международным стандартам.
News
Selexis SA: Launch of Generium's Omalizumab Biosimilar for Atopic Bronchial Asthma Marks Selexis' Ninth Commercial Product
Third Biosimilar to Reach the Market Under Selexis/Generium Commercial License Agreements Selexis SA and Generium JSC today announced that Genolar, Generium's biosimilar of omalizumab, is now commercially
Read more
Report
Generium-next company has launched a workshop for the production of drugs for the treatment of rare diseases
Generium-next company has launched a workshop for the production of drugs for the treatment of rare diseases It is planned that the workshop will produce more than 150 thousand units of products annually and will reach full capacity by the end of 2024. AK
Read more
Report
Launch of Generium's Omalizumab Biosimilar for Atopic Bronchial Asthma Marks Selexis' Ninth Commercial Product
Read more
Report
Generium Launches First Biosimilar of Eculizumab; Becomes Fifth Marketed Product Using Selexis SUREtechnology Platform
Read more
Report
ProMetic Enters Into Strategic Alliance with GENERIUM Pharmaceuticals
ProMetic Life Sciences Inc. - GENERIUM granted exclusive rights to ProMetic
Read more
Report
Pro access
Upgrade to see all 6 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Technologies
Tech DNA
SQL
Visual Basic
AI/ML
SQL
Grafana
Graylog
Loki
Nagios
Zabbix
Other
Visual Basic
Stack modernity
49/100
How modern this stack is, based on technology relevance, AI adoption and the share of legacy tools.
Industry adoption
SQL
14%
Grafana
5%
Zabbix
2%
Visual Basic
2%
Loki
1%
Nagios
1%
Share of companies in the same industry that use each technology.
Stack changes
Visual Basic
Sep 2026
SQL
Sep 2026
Zabbix
Sep 2026
Nagios
Sep 2026
Loki
Sep 2026
Graylog
Sep 2026
Grafana
Sep 2026
Technologies recently added to or removed from this company's stack - a signal of tech migrations and new initiatives.
Jobgether
ITDS Poland
Airbus
CACI International
Software Mind
Thales Alenia Space
Growth
Hiring Momentum
63/100
Growing
Open positions
0
1 opened / 0 closed in 30 days
ATS activity
Every ~11 hours
Today
Hiring Dynamics
0%
Activity Timeline
Added Visual Basic to stack
Sep 2026
Added SQL to stack
Sep 2026
Added Zabbix to stack
Sep 2026
Added Nagios to stack
Sep 2026
Added Loki to stack
Sep 2026
Added Graylog to stack
Sep 2026
Added Grafana to stack
Sep 2026
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Moscow
Russia
Regional office
1000-5000 est. staff
ул. Тестовская, д. 10, подъезд 2, Москва, Россия, 123112, RU